Embecta Corp. (NASDAQ: EMBC) remained unchanged after publishing a diabetes education piece in Mayo Clinic Proceedings.The publication introduces the FITTER Forward Expert Recommendations for insulin injection technique and education.The recommendations aim to enhance clinical outcomes for people with diabetes worldwide.Proper insulin delivery technique plays a crucial role in maintaining target blood glucose levels.